This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Magdalena Platzk
Introduction
Magdalena Platzk is a notable inventor based in Brookline, MA (US). She has made significant contributions to the field of medicine through her innovative research and development of novel compounds. Her work focuses on addressing critical health issues, particularly those related to breathing difficulties.
Latest Patents
Magdalena Platzk holds a patent for "Inhibitors of adrenoreceptor ADRAC2." This patent relates to novel substituted heterocyclic carboxamides and outlines processes for their preparation. The application emphasizes their use in treating and preventing various diseases, including sleep-induced breathing difficulties such as central and obstructive sleep apnea, snoring, dysphagia, and vascular disorders. The potential applications of her invention extend to producing medicaments aimed at treating neurodegenerative and neuroinflammatory disorders.
Career Highlights
Throughout her career, Magdalena has demonstrated a commitment to advancing medical science. Her work at Bayer Aktiengesellschaft has positioned her as a key player in the development of innovative therapeutic solutions. With a focus on improving patient outcomes, she continues to explore new avenues for research and development.
Collaborations
Magdalena has collaborated with esteemed colleagues, including Daniel Meibom and Philipp Buchgraber. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the medical field.
Conclusion
Magdalena Platzk's contributions to innovation in medicine are noteworthy and impactful. Her dedication to developing solutions for complex health issues exemplifies the spirit of invention. Through her work, she continues to inspire future generations of inventors and researchers.